Specialising in innovative life science investments
A venture investor firm backed by a pharmaceutical industry family and managed by an experienced pharma and diagnostics industry team.
Esperante is a corporate venture investment company focussed on investing in mid to late stage clinical stage therapeutics development companies in North America and Europe. Esperante is part of C&P Investors Group, a pharmaceutical group of companies engaged in the development, manufacturing, marketing and sales of diagnostic, ophthalmic, pharmaceutical and peptide-based products and services.
Therapeutic fields of interest
Our portfolio companies are active in the clinical and regulatory phases of development, in pharmaceutical therapeutics and in-vitro diagnostics and the majority are based in Europe and North America. Current therapeutic fields include dermatology, hepatology, infectious disease, oncology and urology.